Jeannette Bankes - 06 May 2022 Form 4 Insider Report for Apollo Endosurgery, Inc.

Role: Director
Signature: /s/ Brian Szymczak - Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 06 May 2022
Net transactions value: $0
Form type: 4
Filing time: 16 Jun 2022, 21:19:26 UTC
Previous filing: 16 Jun 2022
Next filing: 04 Apr 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APEN	Common Stock	Award	$0	+3,417		$0.000000	3,417	06 May 2022	Direct	F1
transaction	APEN	Common Stock	Award	$0	+14,224	+416%	$0.000000	17,641	14 Jun 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APEN	Stock Option (Right to Buy)	Award	$0	+9,533		$0.000000	9,533	06 May 2022	Common Stock	9,533	$5.30	Direct
transaction	APEN	Stock Option (Right to Buy)	Award	$0	+19,333		$0.000000	19,333	14 Jun 2022	Common Stock	19,333	$3.95	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the grant of Restricted Stock Units ("RSUs"). Each RSU provides the Reporting Person with a contingent right to receive one share of the Issuer's common stock. The RSUs vest on April 1, 2023.
F2	Represents the grant of RSUs. Each RSU provides the Reporting Person with a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the one year anniversary of the grant date.